Mason City, Iowa; July 30, 2024 - MercyOne North Iowa Medical Center is proud to announce the successful completion of its first case utilizing the FARAPULSE Pulsed Field Ablation (PFA) System. This state-of-the-art system marks a significant advancement in treating atrial fibrillation and offers safer technology.

Unlike traditional methods, FARAPULSE utilizes short bursts of energy, rather than cold or heat, to address the area of the heart where irregular heartbeats occur. Additionally, this new procedure requires less time than a traditional Afib ablation and does not require an overnight stay.

Atrial fibrillation, commonly known as Afib, can lead to a lifetime of heart rhythm medications, which may bring on potential side effects. It is predicted that by 2030, the number of individuals affected by Afib in the United States will double from 6 million to 12 million. The FARAPULSE Pulsed Field Ablation is a safe, minimally invasive, and proven procedure designed to restore and regulate heartbeats.

Michael Spooner, MD, MercyOne electrophysiologist, and the Cath Lab/Procedure Recovery team at MercyOne introduced the new procedure. The successful implementation of the technology marks an important step forward in the regional health ministry's commitment to providing the best care and innovative treatment options for patients with cardiac conditions.

“We are pleased to have performed the first cardiac ablation procedure in Mason City at MercyOne North Iowa Medical Center using the FARAPULSE Pulsed Field Ablation System,” said Dr. Spooner. “The incidence of atrial fibrillation is on the rise, and such safe, effective and efficient therapies allow physicians to treat more patients, reduce complications and benefit overall public health.”

For more information about MercyOne North Iowa Medical Center, please visit www.mercyone.org/northiowa.

To request an interview with a provider to discuss this subject further, please contact

Hailee Merryman at hailee.merryman@mercyone.org or call 515-341-6885.